Hjem › Waldenstrøms makroglobulinemi › Massachusetts › Boston
Kliniske studier for Waldenstrøms makroglobulinemi i Boston, MA
9 studier for Waldenstrøms makroglobulinemi søker deltakere på steder i og rundt Boston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekruttererFase 1/2
- Dana Farber Cancer Institute, Boston
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
RekruttererFase 2
- Dana Farber Cancer Institute (Data Collection and Specimen Analysis), Boston
- Beth Israel Deaconess Medical Center (Data Collection Only), Boston
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekruttererFase 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM
RekruttererFase 2
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
RekruttererFase 4
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
RekruttererObservasjonsstudie
- Dana-Farber Cancer Institute, Boston
Epcoritamab in Previously Treated WM
RekruttererFase 2
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Study of SGR-1505 in Mature B-Cell Neoplasms
RekruttererFase 1
- Beth Israel Deaconess Medical Center, Boston
A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia
RekruttererFase 2
- Dana Farber Cancer Institute, Boston
Waldenstrøms makroglobulinemi-studier i andre byer
- Durham, NC10 studier
- Denver, CO7 studier
- Rochester, MN6 studier
- New York City, NY6 studier
- Houston, TX6 studier
- Dallas, TX6 studier
- Edison, NJ6 studier
- Seattle, WA5 studier
- Milwaukee, WI5 studier
- Washington, DC4 studier
- Baldwin Park, CA4 studier
- Columbus, OH4 studier
Andre studier i Boston
- Brystkreft112 studier
- Ikke-småcellet lungekreft90 studier
- Kreft (alle typer)85 studier
- Metastatisk kreft63 studier
- Kolorektal kreft63 studier
- Lungekreft62 studier
- Eggstokkreft61 studier
- Prostatakreft59 studier
- Depresjon52 studier
- Endometriekreft50 studier
- Hjertesvikt44 studier
- Akut myelogen leukemi44 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.